AGM Statement

RNS Number : 7979V
Advanced Medical Solutions Grp PLC
03 June 2008
 



For immediate release

June  2008



Advanced Medical Solutions Group plc 

('AMS' or 'the Company')


Annual General Meeting


WinsfordUK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, will hold its Annual General Meeting at 11.00am this morningDr Geoffrey Vernon, the Company's Chairman, will make the following comments on current trading:


“I am pleased to advise that the strong start to the year reported in the Preliminary Results announced on 11th March 2008 has continued. Our current run-rate and the visibility of our order book mean that the Company is trading at the top end of market expectations for the full year 2008.

“The outlook remains positive with the silver alginate business continuing to grow and our ActivHeal® woundcare range continuing to gain wider acceptance within the NHS. The recent re-classification of topical tissue adhesives by the FDA is a highly beneficial step in obtaining accelerated US approval for our LiquiBand™ range.

“The joint venture agreement announced on 19th May 2008 relating to the Corpura hydrophilic polyurethane foam business is another exciting development for AMS and we believe that this agreement will underpin the growth of our foam based wound dressings business. In particular, the joint venture will allow us to accelerate the development of proprietary foam based products using AMS’s higher value technologies such as silver.”
 


For further information, please contact:


Advanced Medical Solutions Group plc


Don Evans, Chief Executive Officer

Mary Tavener, Finance Director

www.admedsol.com

  

  Tel: +44 (0) 1606 545508



Buchanan Communications

Tel: +44 (0) 20 7466 5000

Mark Court, Mary-Jane Johnson


Landsbanki Securities (UK) Ltd

Shaun DobsonClaes Spang



Tel: +44 (0) 20 7426 9000



Notes to Editors:


Advanced Medical Solutions is a leading company in the development, manufacture and sale of products into the $15 billion global woundcare market.


Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure.


In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery ready for distribution into customer markets.


AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 


AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSSAFAESASEDM
UK 100